Cost-effectiveness of sofosbuvir-based treatments for chronic hepatitis C in the US

被引：0
|
作者：
Sai Zhang
Nathaniel D. Bastian
Paul M. Griffin
机构：
[1] Georgia Institute of Technology,School of Industrial and Systems Engineering
[2] Penn State University,Department of Industrial Engineering
来源：
BMC Gastroenterology | / 15卷
关键词：
Cost-effectiveness; Markov model; Sofosbuvir; Harvoni; Olysio; Viekira Pak; Chronic hepatitis C;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Cost-effectiveness of sofosbuvir-based treatments for chronic hepatitis C in the US
    Zhang, Sai
    Bastian, Nathaniel D.
    Griffin, Paul M.
    [J]. BMC GASTROENTEROLOGY, 2015, 15
  • [2] Cost-effectiveness analysis of sofosbuvir-based regimens for chronic hepatitis C
    Miguel, Ramon San
    Gimeno-Ballester, Vicente
    Blazquez, Antonio
    Mar, Javier
    [J]. GUT, 2015, 64 (08) : 1277 - U122
  • [3] Cost-Effectiveness of Sofosbuvir-Based Triple Therapy for Untreated Patients With Genotype 1 Chronic Hepatitis C
    Petta, Salvatore
    Cabibbo, Giuseppe
    Enea, Marco
    Macaluso, Fabio Salvatore
    Plaia, Antonella
    Bruno, Raffaele
    Gasbarrini, Antonio
    Craxi, Antonio
    Camma, Calogero
    [J]. HEPATOLOGY, 2014, 59 (05) : 1692 - 1705
  • [4] Sofosbuvir-Based Treatment Regimens for Chronic, Genotype 1 Hepatitis C Virus Infection in US Incarcerated Populations A Cost-Effectiveness Analysis
    Liu, Shan
    Watcha, Daena
    Holodniy, Mark
    Goldhaber-Fiebert, Jeremy D.
    [J]. ANNALS OF INTERNAL MEDICINE, 2014, 161 (08) : 546 - U43
  • [5] SOFOSBUVIR-BASED ALL-ORAL TREATMENT FOR ELDERLY CHRONIC HEPATITIS C PATIENTS: A COST-EFFECTIVENESS ANALYSIS
    Ciaccio, A.
    Cortesi, P. A.
    Bellelli, G.
    Rota, M.
    Okolicsanyi, S.
    Rota, M.
    Mantovani, L.
    Annoni, G.
    Strazzabosco, M.
    [J]. DIGESTIVE AND LIVER DISEASE, 2015, 47 : E15 - E16
  • [6] Cost-effectiveness analysis of sofosbuvir-based regimens for chronic hepatitis C virus genotype 1 infection in China
    Li, Fan
    Chen, Guofeng
    Shao, Qing
    Ji, Dong
    Li, Bing
    Li, Zhongbin
    Liu, Jialiang
    Liu, Chunxiao
    Wang, Tingting
    Wang, Qiaomin
    Chen, Jing
    Wu, Vanessa
    Wong, April
    Wang, Cheng
    Wang, Yudong
    Lau, George K.
    [J]. HEPATOLOGY, 2015, 62 : 959A - 960A
  • [7] Cost-effectiveness of Sofosbuvir-based hepatitis C regimens in Central and West Africa (ANRS 12342)
    Boyer, S.
    Baudoin, M.
    Nishimwe, M.
    Woode, M. E.
    Maradan, G.
    Lemoine, M.
    Sylla, B.
    Kouanfack, C.
    Carrieri, P.
    Rouveau, N.
    Moh, R.
    Seydi, M.
    Attia, A.
    Lacombe, K.
    [J]. JOURNAL OF HEPATOLOGY, 2018, 68 : S184 - S185
  • [8] SOFOSBUVIR-BASED DIRECT-ACTING ANTIVIRALS TREATMENT FOR ELDERLY CHRONIC HEPATITIS C PATIENTS: A COST-EFFECTIVENESS ANALYSIS
    Ciaccio, A.
    Cortesi, P. A.
    Bellelli, G.
    Rota, Matteo
    Rota, Monica
    Okolicsanyi, S.
    Mantovani, L. G.
    Annoni, G.
    Strazzabosco, M.
    [J]. JOURNAL OF HEPATOLOGY, 2015, 62 : S639 - S639
  • [9] The Cost-Effectiveness of Sofosbuvir-Based Regimens for Treatment of Hepatitis C Virus Genotype 2 or 3 Infection
    Linas, Benjamin P.
    Barter, Devra M.
    Morgan, Jake R.
    Pho, Mai T.
    Leff, Jared A.
    Schackman, Bruce R.
    Horsburgh, C. Robert
    Assoumou, Sabrina A.
    Salomon, Joshua A.
    Weinstein, Milton C.
    Freedberg, Kenneth A.
    Kim, Arthur Y.
    [J]. ANNALS OF INTERNAL MEDICINE, 2015, 162 (09) : 619 - U220
  • [10] A COST COMPARISON OF TREATING CHRONIC HEPATITIS C PATIENTS WITH SOFOSBUVIR-BASED REGIMENS
    Ru, H.
    Zhou, J.
    [J]. VALUE IN HEALTH, 2018, 21 : S224 - S224
12345